News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
CNS Drug Development Resources|
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos
Advertisement

Paula McHale

Advertisement

Articles by Paula McHale

i3_t-820668-1408537178339.jpg

Risk-Based Approaches

ByJules T. Mitchel, MBA, PhD,Paula McHale,Lisa Lucero,Selina Sibbald,Debbie McCann,Patrick Nadolny,Ioannis Karageorgos,Dean A. Gittleman,Darlene Kalinowski,Robert King,Julie M. Brothers,Thomas Haag,Brett Wilson
August 1st 2013

The eClinical Forum Risk Based Monitoring Taskforce offers some best practices for ensuring clinical data quality.

Advertisement

Latest Updated Articles

  • i3_t-820668-1408537178339.jpg
    Risk-Based Approaches

    Published: August 1st 2013 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor

2

Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes

3

Future-Proofing Clinical Trial Supply Chains Against Tariff Risks

4

After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies

5

Labels That Withstand Liquid Nitrogen

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us